Collectively, these findings suggest that tumoral tissues, herein exemplified by HNSCC and lung cancers might be more resistant to SARS-CoV-2 infection due to reduced expression of TMPRSS2. This evidence concerns the gene TMPRSS2 and head and neck squamous cell carcinoma.